Tauriga Sciences Inc. Signs Definitive Agreement to Acquire Synthetic Biology Developer Pilus Energy LLC

Tauriga Sciences Inc. Signs Definitive Agreement to Acquire Synthetic Biology
Developer Pilus Energy LLC

NEW YORK, Nov. 25, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG)
or ("Tauriga" or "the Company"), a diversified company focused on generating
profitable revenues through license agreements and the development of a
proprietary technology platform in the nanorobotics space, has today announced
the execution of a definitive agreement to acquire Cincinnati, Ohio based
Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy
platforms using proprietary microbial solutions that creates electricity while
consuming polluting molecules from wastewater. Upon consummation of the
proposed reverse merger, which has been unanimously ratified by Tauriga's
board of directors, Pilus Energy will become a wholly-owned subsidiary of
Tauriga. In addition certain advisors of Pilus Energy will be incorporated
into the existing management team of Tauriga and will report directly to the
Company's CEO, Seth M. Shaw and COO, Dr. Stella M. Sung.

Pilus Energy LLC utilizes a proprietary clean technology to convert industrial
customer "wastes" into value. This waste-to-value ("WTV") proposition provides
customers with substantial revenue-generating and cost-saving
opportunities.Pilus Energy is converging digester, fermenter, scrubber, and
other proven technologies into a scalable Electrogenic Bioreactor ("EBR")
platform.This transformative technology is the basis of the Pilus Cell™. The
EBR harnesses genetically enhanced bacteria, also known as bacterial robots,
or BactoBots™, that remediate water, harvest direct current (DC) electricity,
and produce economically important gases.The EBR accomplishes this through
bacterial metabolism, specifically cellular respiration of nearly four hundred
carbon and nitrogen molecules.Pilus Energy's highly metabolic bacteria are
non-pathogenic. Because of the mediated biofilm formation, these
wastewater-to-value BactoBots resist heavy metal poisoning, swings of pH, and
survive in a 4-to-45 degree Celsius temperature range. Additionally the
BactoBots are anaerobically and aerobically active, even with low BOD/COD.

Under terms of this definitive agreement, each membership unit of Pilus Energy
will be converted into warrants exercisable for common stock of Tauriga.In
addition, Tauriga anticipates the appointment of new directors and officers
following the proposed acquisition.

The main closing terms include the issuance of warrants exercisable for an
aggregate of 100,000,000 shares of TAUG common stock to the members of Pilus
Energy, the successful completion by Tauriga of a $2,250,000 USD capital
raise, which the Company has a maximum of 180 days to complete, and the
satisfactory completion of comprehensive due diligence by Tauriga, among other
closing conditions.As a condition to the transaction, Pilus Energy will
obtain an exclusive license to the technology described above from Bacterial
Robotics LLC, the parent of Pilus Energy.

The requisite capital raise, mentioned above as a main closing term, is
specifically for the purpose of funding two distinct Pilus Energy pilot
programs, which if successful, could result in significant high margin
revenues for the Company over the coming years.These two planned pilot
programs, ready to be initiated upon closing, are with Fortune 500 Company
Anheuser-Busch InBev ("Anheuser-Busch"), a global brewing company, engaged in
the production, marketing, distribution, and sale of beer, and the
Metropolitan Sewer District ("MSD") of Greater Cincinnati, which serves the
wastewater removal and treatment needs of over 800,000 residents and
businesses in Hamilton County, Ohio.

Jason E. Barkeloo, currently the President of Pilus Energy, will elected to
the Company's business advisory board and will continue to serve as CEO of
Bacterial Robotics LLC ("Bacterial Robotics"), an existing strategic partner
of Tauriga's developing a bacterial robot ("BactoBot™") for the nuclear power
industry.Tauriga continues to make excellent progress in the development of
the nuclear energy BactoBot ("NuclearBot™") and the Company's merger with
Pilus Energy will not result in a loss of focus or momentum with respect to
these efforts.

Tauriga's CEO Seth M. Shaw commented, "The completion of this definitive
merger agreement marks a major milestone for both companies and their
stockholders and their shared goals of commercializing industry specific
bacterial robots to benefit both industry and society.The quality of the
relationships developed by Pilus Energy is a testament to both their
innovative technology platform and talented management team and
affiliates.Additionally the completion of this merger would provide Tauriga
with a powerful business model capable of producing significant recurring
revenues with a strong built in net profit margin."

Pilus Energy's outgoing President, Jason E. Barkeloo stated, "The management
team of Tauriga has demonstrated the level of commitment, competency, and
integrity required to successfully commercialize the cutting edge technology
being developed and tested by Pilus Energy.Once the pilot programs are
funded, the potential for revenue generation and profitability is quite
compelling.I look forward to working closely with the combined management
team to create lasting shareholder value and establishing a high growth

The Global 100 law firm, Nixon Peabody LLP represented Tauriga Sciences Inc.
on this definitive merger agreement with Pilus Energy LLC and will continue to
represent the company moving forward.The Company anticipates the closing of
this merger during the first calendar quarter of 2014 but will continue to
update shareholders on developments that may affect the ultimate closing

About Tauriga Sciences, Inc.:

Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating
profitable revenues through license agreements and the development of a
proprietary technology platform in the nano-robotics space. The mission of the
Company is to acquire and build a diversified portfolio of cutting edge
technology assets that is capital efficient and of significant value to the
shareholders. The Company's business model includes the acquisition of
licenses, equity stakes, rights on both an exclusive and non-exclusive basis,
and entire businesses. Management is firmly committed to building lasting
shareholder value in the short, intermediate, and long terms. The Company's
new corporate website can be found at (www.tauriga.com).

About Pilus Energy LLC

A developer of alternative cleantech energy solutions, Pilus Energy is
developing microbial solutions that clean polluting molecules from wastewater.
In the process, the technology generates electricity and produces economically
important gases and chemicals. Pilus Energy licenses a low-cost, scalable
electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus
Energy will also derive additional revenues from carbon and renewable energy
credits (REC). For more information, please visit Pilus Energy's web site,

About Bacterial Robotics LLC

An early developer in the emerging evolutionary engineering industry,
Bacterial Robotics is headquartered in Cincinnati, Ohio (USA).The Company
specializes in identifying markets for developing and deploying BactoBots™ and
ViruBots™; microscopic organism-based robots that produce, build, sense, and
perform functions.

The Company's products will be protected by a proprietary genetics rights
management (GeRM™) key system.The GeRM system is a consumable additive that
prevents the BactoBots against theft or release into the environment.The GeRM
enables the Company to gain licensing revenues from the local manufacture and
distribution of its BactoBots.For more information on Bacterial Robotics,
visit its web site at http://BacterialRobotics.com.


Forward-Looking Statements: Except for statements of historical fact, this
news release contains certain "forward-looking statements" as defined by the
Private Securities Litigation Reform Act of 1995, including, without
limitation expectations, beliefs, plans and objectives regarding the
development, use and marketability of products. Such forward-looking
statements are based on present circumstances and on TAUG's predictions with
respect to events that have not occurred, that may not occur, or that may
occur with different consequences and timing than those now assumed or
anticipated. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors, and are not guarantees of future performance
or results and involve risks and uncertainties that could cause actual events
or results to differ materially from the events or results expressed or
implied by such forward-looking statements. Such factors include general
economic and business conditions, the ability to successfully develop and
market products, consumer and business consumption habits, the ability to fund
operations and other factors over which TAUG has little or no control. Such
forward-looking statements are made only as of the date of this release, and
TAUG assumes no obligation to update forward-looking statements to reflect
subsequent events or circumstances. Readers should not place undue reliance on
these forward-looking statements. Risks, uncertainties and other factors are
discussed in documents filed from time to time by TAUG with the Securities and
Exchange Commission. This press release does not and shall not constitute an
offer to sell or the solicitation of any offer to buy any of the securities,
nor shall there be any sale of the securities, in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state. The securities
have not been registered under the Securities Act of 1933, as amended (the
"Securities Act") or any state securities laws, and may not be offered or sold
in the United States absent registration, or an applicable exemption from
registration, under the Securities Act and applicable state securities laws.

CONTACT: Tauriga Sciences, Inc.:
         Mr. Seth M. Shaw
         Chairman & Chief Executive Officer
         Tauriga Sciences, Inc.
         New York: +1-917-796-9926
         Montreal: +1-514-840-3697
         Email: sshaw@tauriga.com
         Bacterial Robotics LLC
         Jason E. Barkeloo
         Chief Executive Officer
         Cincinnati:  +1-513-252-2901
         Twitter:  @BactoBot at http://twitter.com/BactoBot
         Info:     http://BacterialRobotics.com/contact/
         Email:  info@BacterialRobotics.com

Tauriga logo
Press spacebar to pause and continue. Press esc to stop.